Open Access Pre-publication history

A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors

Joseph P Connor*, Mihaela C Cristea, Nancy L Lewis, Lionel D Lewis, Philip B Komarnitsky, Maria R Mattiacci, Mildred Felder, Sarah Stewart, Josephine Harter, Jean Henslee-Downey, Daniel Kramer, Roland Neugebauer and Roger Stupp

BMC Cancer 2013, 13:20  doi:10.1186/1471-2407-13-20

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 14 Jun 2012
Reviewer's Report jason chesney 29 Aug 2012
Reviewer's Report Michael Morse 29 Sep 2012
Reviewer's Report Mayer Fishman 19 Oct 2012
Resubmission - Version 2 Manuscript Author's comment 21 Dec 2012
Editorial acceptance 11 Jan 2013
Published 15 Jan 2013